Genome & Company (KOSDAQ:314130)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,845.00
+135.00 (4.98%)
At close: Oct 10, 2025

Genome & Company Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
88,43885,207176,209245,897468,8271,048,465
Upgrade
Market Cap Growth
-21.81%-51.64%-28.34%-47.55%-55.28%224.28%
Upgrade
Enterprise Value
82,49689,070151,242185,907383,8411,026,945
Upgrade
Last Close Price
2845.002750.006245.008725.0017350.0039750.00
Upgrade
PS Ratio
3.683.0712.3317.461038.966962.78
Upgrade
PB Ratio
0.870.861.551.634.139.11
Upgrade
P/TBV Ratio
1.603.404.833.738.109.84
Upgrade
EV/Sales Ratio
3.433.2110.5813.20850.636819.87
Upgrade
Debt / Equity Ratio
0.270.320.230.040.060.02
Upgrade
Asset Turnover
0.160.180.090.090.000.00
Upgrade
Inventory Turnover
1.962.593.534.76--
Upgrade
Quick Ratio
2.672.803.099.838.0336.89
Upgrade
Current Ratio
2.993.083.3610.498.3237.00
Upgrade
Return on Equity (ROE)
-30.76%-25.26%-38.36%-43.15%-31.51%-80.88%
Upgrade
Return on Assets (ROA)
-11.34%-9.78%-20.55%-23.17%-17.48%-21.33%
Upgrade
Return on Capital (ROIC)
-12.64%-11.16%-23.20%-25.95%-19.03%-38.58%
Upgrade
Earnings Yield
-30.62%-23.60%-26.94%-21.08%-7.28%-2.93%
Upgrade
FCF Yield
-23.12%-23.82%-28.99%-20.50%-6.19%-1.88%
Upgrade
Buyback Yield / Dilution
-5.98%-7.88%-0.32%-4.71%-39.60%-20.11%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.